Insider · CIK 0001204144
Gregory D Waller
Files at RKDA (Arcadia Biosciences, Inc.), NUWE (Nuwellis, Inc.). First filing -, latest -.
Gregory D Waller files SEC Form 4 as director at RKDA (Arcadia Biosciences, Inc.), and also at NUWE (Nuwellis, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Gregory D Waller has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | RKDA Arcadia Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 23,338 | 29 d ago |
| Apr 28, 2026 | NUWE Nuwellis, Inc. | AGrant or award Nonstatutory Stock Option (right to buy)derivative | +6,744 | $0.00 | $0 | 6,744 | Apr 29, 2026 |
| May 20, 2025 | NUWE Nuwellis, Inc. | AGrant or award Nonstatutory Stock Option (right to buy)derivative | +17,496 | $0.00 | $0 | 17,496 | May 21, 2025 |
Questions about Gregory D Waller
Answered from the filings on this page, as of the latest one.
Is Gregory D Waller buying or selling?
Gregory D Waller has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Gregory D Waller's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gregory D Waller has 0.
Where does Gregory D Waller file Form 4?
Gregory D Waller has filed Form 4 at RKDA (Arcadia Biosciences, Inc.); NUWE (Nuwellis, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.